期刊文献+

1H-MRS观察帕金森病患者延髓及黑质代谢 被引量:9

~1H-MRS in observation of metabolism of medulla oblongata and substantia nigra in Parkinson disease
下载PDF
导出
摘要 目的采用1H-MRS分析帕金森病(PD)患者延髓及患侧黑质中主要代谢物的改变及其与临床病情的关系。方法 选取PD患者17例(PD组),正常对照17名(正常对照组)。采用Philips1.5T磁共振成像系统单体素1H-MRS技术,选取延髓及患侧黑质作为感兴趣区进行MRS扫描,获取N-乙酰天门冬氨酸(NAA)、胆碱(Cho)、肌酸(Cr)峰下面积,计算NAA/Cr、Cho/Cr比值。结果 PD组延髓和患侧黑质与正常对照组比较,NAA/Cr、Cho/Cr比值差异均无统计学意义。PD患者延髓NAA/Cr、Cho/Cr比值与临床指标未发现显著相关性。PD患者患侧黑质NAA/Cr比值与UPDRS评分(r=-0.686,P=0.007)及UPDRS运动评分(r=-0.724,P=0.004)显著负相关;Cho/Cr比值与UPDRS评分(r=-0.770,P=0.002)及UPDRS运动评分(r=-0.843,P<0.001)呈显著负相关。患侧黑质处NAA/Cr、Cho/Cr与H&Y分级呈显著负相关(r=-0.697、-0.715,P=0.012、0.009)。结论 采用1H-MRS检测延髓及患侧黑质NAA、Cho尚不能作为诊断PD的手段。检测患侧黑质代谢物改变能够反映患PD者病情进展情况。 Objective To investigate the metabolic changes in medulla oblongata and unilateral substantia nigra of Parkinson's disease with 1H-magnetic resonance spectroscopy(1H-MRS),and to observe their correlation with clinical conditions of Parkinson disease(PD) patients.Methods Totally 17 PD patients(PD group) and 17 healthy subjectd(control group) were enrolled.Philips 1.5T MRI scanner was used.The medulla oblongata(MO) and the unilateral substantia nigra(SN) were selected as ROI.N-acetyl aspartate(NAA),Choline(Cho),creatine(Cr) peak area and calculated NAA/Cr and Cho/Cr ratio were obtained.Results No significant difference was observed between the PD and control groups for NAA/Cr and Cho/Cr in MO and SN.There was no obvious correlation between metabolite ratios(NAA/Cr and Cho/Cr) with clinical indexes in MO.For SN,NAA/Cr and Cho/Cr ratios in PD patients showed significant negative correlation with UPDRS score(r=-0.686,P=0.007;r=-0.770,P=0.002) and UPDRS motor score(r=-0.724,P=0.004;r=-0.843,P0.001).The NAA/Cr,Cho/Cr ratio had significant negative correlation with HY classification(r=-0.697,-0.715,P=0.012,P=0.009) in SN.Conclusion 1H-MRS can not be used as a tool for early diagnosis of PD.Metabolites changes in unilateral substantia nigra can reflect the progress of PD.
出处 《中国医学影像技术》 CSCD 北大核心 2011年第1期27-31,共5页 Chinese Journal of Medical Imaging Technology
基金 陕西省科技攻关项目(2009K16-01)
关键词 帕金森病 磁共振波谱 延髓 黑质 Parkinson disease Magnetic resonance spectroscopy Medulla oblongata Substantia nigra
  • 相关文献

参考文献14

  • 1Marras C, Lang A. Invited article: changing concepts in parkin-son disease-moving beyond the decade of the brain. Neurology, 2008,70(21) :1996-2003.
  • 2Braak H, Del Tredici K, Rub U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging, 2003,24(2) : 197-211.
  • 3Majos C, Julia-Sape M, Alonso J, et al. Brain tumor classification by proton MR spectroscopy: comparison of diagnostic aecuracy at short and long TE. AJNR Am J Neuroradiol, 2004,25(10) 1696-1704.
  • 4沈金丹,沈桂权,范光明.DWI与^1H MRS基本原理及其在脑肿瘤中的应用[J].中国医学影像技术,2008,24(7):1121-1124. 被引量:10
  • 5Mascalchi M, Brugnoli R, Guerrini L, et al. Single-voxel long TE ^1H-MR spectroscopy of the normal brainstem and cerebellum. J Mag Reson Imaging, 2002,16(5) :532-537.
  • 6邢永红,周官恩,张本恕,张云亭,安中平.质子磁共振波谱用于帕金森病黑质代谢研究价值的探讨[J].中风与神经疾病杂志,2007,24(1):79-82. 被引量:6
  • 7李鹏,王伟,古艳,李杨,陈兢,徐咏华,黄景唏.改良质子磁共振波谱技术观察帕金森病患者黑质内神经代谢的改变[J].中国临床康复,2006,10(34):112-114. 被引量:3
  • 8Choe BY, Park JW, Lee KS, et al. Neuronal laterality in Parkinson's disease with unilateral symptom by in vivo ^1H magnetic resonance spectroscopy. Invest Radiol, 1998,33(8):450-455.
  • 9陈薇,谢惠君,汪剑.磁共振波谱分析在帕金森病早期诊断应用中的价值[J].中国临床康复,2004,8(1):34-35. 被引量:26
  • 10Ellis CM, Lemmens G, Williams SCR, et al. Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: A proton magnetic resonance spectroscopy study. Neurology, 1997,49(2) : 438-444.

二级参考文献60

  • 1刘梅丽,崔世民,韩彤,刘力,雷静,刘红军,张云亭.弥漫性星形细胞肿瘤的活体^1H MR波谱及灌注成像和扩散成像分级[J].中华放射学杂志,2007,41(2):153-157. 被引量:8
  • 2Naruse S,Kizu O,Furuya S.The role of magnetic resonance spectroscopic imaging in patients with Parkinson's disease.Nippon Rinsho 1997,55(1):262-4
  • 3O'Neill J,Schuff N,Marks WJ Jr,et al.Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease.Mov Disord 2002,17(5):917-27
  • 4Federico F,Simone IL,Lucivero V,et al.Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders.Mov Disord 1997,12(6):903-9
  • 5Lucetti C,Del Dotto P,Gambaccini G,et al.Proton magnetic resonance spectroscopy (1H-MRS) of motor cortex and basal ganglia in de novo Parkinson's disease patients.Neurol Sci 2001,22(1):69-70
  • 6Clarks CE,Lowry M.Systematic review of proton magnetic resonance spectroscopy of the striatum in parkinsonian syndromes.Eur J Neurol 2001,8 (6):573-7
  • 7Holshouser BA,Komu M,Moller HE,et al.Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease:a multicenter pilot study.Magn Reson Med 1995,33(5):589-94
  • 8Taylor-Robinson SD,Turjanski N,Battacharrya S,et al.A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in parkinson's disease.Metab Brain Dis 1999,14(1):45-55
  • 9Bowen BC,Block RE,Sanchez-Ramos J,et al.Proton MR spectroscopy of the brain in 14 patients with Parkinson disease.AJNR Am J Neuroradiol 1995,16(1):61-8
  • 10Firbank MJ,Harrison RM,O'Brien JT.A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease.Dement Geriatr Cogn Disord 2002,14(2):64-76

共引文献38

同被引文献46

引证文献9

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部